European investment firm LSP has closed its European life sciences fund LSP at €1 bn. Additionally, a €10bn fund of funds was greenlighted at the EU Council in Paris.
AiCuris will pay up to €100m to Dutch Hybridize Therapeutics BV for the development of antisense RNA therapeutics that stop BK viraemia in renal transplant patients.
Laurence Riot Lamotte has started at the beginning of 2022 als new Chief Financial Officer of French Diaccurate. She succeeds José Da Gloria, who left the company.
AGC Biologics supports BioNTech’s manufacturing of an Omicron-based vaccine with plasmids for in vitro transcription.
EU Members States agreed on Tuesday to launch the pan-European Scale-up Initiative, which is aimed to provide €10bn for late-state tech companies.
Dutch insect protein specialist Protix has raised €50m for expansion and development from international investors and the ECBF.
Co-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, who is retiring.
A rapid antigen test provides a fast and reliable indication of the presence of the SARS-CoV-2 virus, the causative agent of Covid-19. A positive result of an antigen test is reliable, whereas a negative result does not completely rule out infection with the SARS-CoV-2 virus. The success of rapid tests is therefore limited by the sensitivity of the antibodies used.
Ribbon Biolabs has cashed in €18m in Series A financing led by Hadean Ventures
German mRNA and LNP specialist Ethris GmbH has closed a $26m Series B round led by Laureus Capital.